SBC Medical Group Holdings reported a strong third quarter for 2026, with revenue rising 35% year-over-year to $59 million. The company's Adjusted EBITDA surged 66% to $28 million, supported by service fee revisions and the consolidation of Waqoo. While net income grew 22% to $16 million, the company maintains a robust balance sheet with $154 million in net cash to fund future growth initiatives.
Bullish
🤖 85%
Third-quarter results show a sharp reacceleration: revenue up 35% year-over-year to $59 million, income from operations up 66%, net income up 22% to $16 million, and Adjusted EBITDA up 66% to $28 million with a 47% margin. Growth was driven by service fee revisions announced in August and the consolidation of Waqoo. Strong profits and balance sheet ($154 million net cash) support the shares, though net income margin slipped 3 points to 27%.
Catalysts
- ▲ Q3 2026 revenue of $59 million, up 35% year-over-year, with Adjusted EBITDA up 66% to $28 million
- ▲ Basic EPS of $0.15 vs $0.12, up 25% year-over-year
Risk Factors
- ▼ Net income margin declined 3 points to 27% versus the prior-year quarter
- ▼ Nine-month net income grew only 2% and nine-month revenue 13%, far slower than the third-quarter pace